GSK says senior executives appear to have broken Chinese law
LONDON (Reuters) - GlaxoSmithKline (GSK.L), facing a major bribery scandal in China, said on Monday that some of its executives in the country appeared to have broken the law.
"Certain senior executives of GSK China, who know our systems well, appear to have acted outside of our processes and controls which breaches Chinese law," the British drugmaker's head of emerging markets, Abbas Hussain, said in a statement.
Hussain, who was sent to China last week to lead GSK's response to the crisis, held a meeting with the Ministry of Public Security at which he also promised to review GSK's business model, leading to price reductions in the country.
(Reporting by Ben Hirschler, Editing by Brenda Goh)
- Air strike kills 15 civilians in Yemen by mistake: officials
- Pope attacks mega-salaries and wealth gap in peace message
- North Korea says Jang Song Thaek, uncle of leader Kim Jong Un, executed
- Probation for drunk Texas teen driver who killed four sparks backlash
- North Korea executes leader's powerful uncle in rare public purge |